Mitochondrial protonophoric activity induced by a thyromimetic fatty acid analogue

  • Hermesh O
  • Kalderon B
  • Berman B
 et al. 
  • 5

    Readers

    Mendeley users who have this article in their library.
  • 13

    Citations

    Citations of this article.

Abstract

Calcium-dependent uncoupling of liver mitochondrial oxidative phosphorylation by a non-metabolizable long chain fatty acyl analogue was compared with uncoupling induced by in vivo thyroid hormone treatment. β,β'-Methyl-substituted hexadecane α,ω-dioic acid (Medica 16) is reported here to induce a saturable 20-30% decrease in liver mitochondrial ΔΨ, ΔpH and protonmotive force which proceeds in the presence of added Ca2+ to cyclosporin A-sensitive mitochondrial permeabilization. Ca2+-dependent uncoupling by Medica 16 was accompanied by atractylate-enhanced, bongkrekic-inhibited activation of mitochondrial Ca2+ efflux. The direct mitochondrial effect exerted in vitro by Medica 16 is similar to that induced by in vivo thyroid hormone treatment. Hence, the thyromimetic protonophoric activity of Medica 16 and the uncoupling activity of TH converge onto components of the mitochondrial permeabilization transition pore. Copyright (C) 2000 Elsevier Science B.V.

Author-supplied keywords

  • Fatty acid
  • Mitochondria
  • Thyroid hormone
  • Uncoupling

Get free article suggestions today

Mendeley saves you time finding and organizing research

Sign up here
Already have an account ?Sign in

Find this document

Authors

  • Orit Hermesh

  • Bella Kalderon

  • Benjamin Berman

  • Jacob Bar-Tana

Cite this document

Choose a citation style from the tabs below

Save time finding and organizing research with Mendeley

Sign up for free